26. ICOSIM Weekly

1. This is how to handle radiation exposure responsibly
2. Save The Date: International Congress for Integrative Dentistry December 1st and 2nd, ’23

Dear friends of ICOSIM and
jawbone osteoimmunology,

 

It is recommended to read the current S2k guideline (long version) on radiation exposure DVT-justifying indication from both the perspective of patient protection and forensic aspects.

Here are four points from the perspective of radiation-free ultrasound sonography in dental, oral, and maxillofacial medicine for science-oriented ICOSIM members:

 

1.I. Dental digital volume tomography – DVT

AWMF registration number: 083-005 Status: December 2022 Valid until: December 2027

The implantological operator should be aware of the increased radiation exposure associated with DVT compared to two-dimensional imaging.

…However, three-dimensional imaging may still be justified for orofacial pathologies and diseases of the jawbone as well as a number of specific indications (European Commission 2012; Kapila and Nervina 2015; P. Jaju and S. Jaju 2015). The justifying indication requires the determination that the health benefit of the application outweighs the radiation risk. Other procedures with comparable health benefits that are associated with no or lower radiation exposure should be considered in the evaluation.

…Whereby the radiation exposure caused by an X-ray examination is to be limited as far as possible in accordance with the requirements of medical science (ALARA principle). When selecting the respective procedure, it should be taken into account that DVT application is associated with at least 10 times the effective dose compared to intraoral tube or bite-wing radiography.

Since there is still insufficient evidence for the use of DVT technology in childhood and adolescence for many questions, the indication must be carefully weighed on a case-by-case basis (European Commission 2004; European Commission 2012). A replacement production of a DVT recording exclusively for subsequent calculation of two-dimensional recordings (e.g. panoramic reconstruction or remote X-ray lateral recording) is not justified for radiation protection reasons.

In the application, the internationally established ALARA principle should generally be followed. Increasingly, the ALADA (as low as diagnostically acceptable) principle is also applied, which focuses on optimizing radiation dose in medical imaging, as proposed by the National Council on Radiation Protection and Measurements (NCRP) (White et al., 2012; Yeung, Jacobs, & Bornstein, 2019).

Risk assessments are difficult at low dose levels and are mainly based on the evaluation of cohorts of survivors of the atomic bombings in Japan in 1945 in combination with the internationally accepted “Linear No Threshold (LNT) assumption” in radiation protection (BEIR, 2006).

The estimated risk of dying from exposure to ionizing radiation from a DVT scan (risk of exposure-induced death (REID)(BEIR 2006)) is on average six cases per million (Pauwels et al., 2014), with women having a 40% higher risk than men on average (Pauwels et al., 2014). Another study calculated twice the risk for ten-year-olds compared to thirty-year-olds (Yeh & Chen, 2018).

In accordance with the optimization principle known in radiation protection, the possibilities for using dose-saving techniques, especially in the production of DVT images in children and adolescents as well as the S2k guideline “Dental digital volume tomography” long version as of December 2022© ARö, DGZMK 16 should be exhausted as far as possible (Federal Government of Germany 2018).

II. Bone density and DVT

In addition, it should be noted that structures located outside the image-generating FOV can lead to increased image noise due to the local tomography effect (Arai et al. 1999; Daatselaar, van der Stelt, and Weenen 2004; Katsumata et al. 2009).

For example, in peri-implantitis diagnosis, diagnostics of the immediate peri-implant environment (such as osseointegration of a dental implant) is only possible to a limited extent due to artifacts in DVT and CT (Draenert et al. 2007; Schulze, Berndt, and d’Hoedt 2010). To what extent DVT is possible against the background of existing imaging errors in the immediate vicinity of implant imaging cannot be reliably clarified based on current scientific data.

 

III. Is Hounsfield validated in DVT?

Currently, there are no randomized or controlled studies in patients that demonstrate the benefits of three-dimensional diagnostics with regard to the quality of surgical outcomes and/or the frequency of complications in implantology.

However, it should be noted that comparisons of noise between DVT devices or with CT are currently not valid, as the required calibration of Hounsfield units is not currently available on any DVT device (Blendl et al. 2012; Pauwels, Jacobs et al. 2015).

The gray values displayed in DVT are not standardized, unlike the values normalized over the Hounsfield scale in CT. Therefore, a quantitative use of gray values in DVT images, such as for bone density estimation, is not possible between different devices (Bornstein, W. Scarfe et al. 2014).

 

IV. Conclusion

a) Radiation exposure is harmful; its immunological safety is not proven. The Linear No Threshold (LNT) assumption applies internationally. There is no reliable “threshold” because the summation effect of radiation doses contradicts their health sustainability.

b) Image noise and imaging errors in the immediate implant environment limit DVT statements.

c) Hounsfield units in DVT are neither validated nor reliable.

d) Everyone should think further about their medical and forensic responsibility!

 

Therefore, the following principle applies, which you will also learn in training courses such as a CaviTAU® training: First OPG, then ultrasound examination, and only if the ultrasound examination is positive, then DVT due to radiation protection law (ALARA principle).

 

2. Save The Date 

Further education amidst a picturesque setting?
Plenty of sunshine instead of gray days?

Hans Lechner and other actors, such as the manufacturer CaviTAU®, are represented at the International Congress for Integrative Dentistry in Porto, Portugal with a workshop and lecture: ‘The smouldering fire in the jawbone – Systemic diseases and neglected RANTES inflammation detected by ultrasonography.’

 

To register and for more information, simply click on the button
to go to the congress website.

 



Until the next ICOSIM Weekly, I remain with collegial greetings.

Your Hans Lechner.

25. ICOSIM Weekly

1. Failed augmentation – A letter from a patient documents the need to use a device to measure bone density in augmentations

Dear friends of ICOSIM and
jawbone osteoimmunology,

 

 In this weekly, I present a case study of a patient that documents the need to use a device for measuring bone density in augmentations:

 
I had an implant from SDS, with internal sinus lift, inserted by a specialist about 2 years ago. After a healing time of 7.5 months, the implant was removed again, because it started to wobble 2 weeks after the crown was placed. The dentist pulled the implant out again.
 
After the implant removal, I suffered from dizziness for days. I also have joint pain since then, which I never had before. 
 
I am 58 years old and basically healthy, have good teeth (first denture) and have a
good immune system. My D3 level (87 ng/ml) and other nutrients are very well
present according to blood count.
Therefore, it is unclear why the implant did not hold.
 

My answer 1:

 

a) To your case:

The colleague works with his bone augmentations – like many other dentists – without knowing whether this artificial attempt was successful, because he has no device to determine the bone density of his augmentation so firmly that the inserted implants now hold or not.

With an ultrasound sonography, performable with a CaviTAU® device, he could have checked that and the implant would not have fallen out after loading (by the way, you are not an isolated case; the internet is full of such complaints).

Answer patient:In addition, I am still looking for the right way (implant and bone augmentation including material) and a specialist whom I can trust in this regard. My mother (81 years) got very many implants (no SDS) inserted within one year. She has been physically and mentally very bad since then. Meanwhile, there are expert opinions on her and she was advised to make claims for damages against this dentist.

My answer 2: 

 

b) The problem lies in the constant x-raying and trusting that x-rays reliably show the bone density in the jaw.

  1. BEFORE the implantation – then implants are inserted in not well healed jaws and the patient suffers from reactivated old inflammations (case of your mother).

  2. BEFORE the implantation in bone augmentation – then the dentist does not know whether this augmentation has already healed so firmly that the implant holds (your case).

 

c) To determine the bone or augmentation density in case a) and b), there is the possibility to use the – radiation-free (there is also a radiation protection law for dentists) – ultrasound sonography with the help of CaviTAU®  to avoid cases a) and b) in the interest of patient protection. 

 

Unfortunately, the above-mentioned patient is not an isolated case, as the internet in the USA shows:

Please think of the valuable application of a CaviTAU®-device for augmentations in volume IV, chapter 4.5: TAU for bone augmentation.

You can download a new flyer with information and ordering options here: :

New flyer for information and order here for DOWNLOAD


You can also find the volumes directly in our ICOSIM SHOP:

To the SHOP literature overview

 

I look forward to your numerous feedbacks on this completely unresolved problem in the entire implantation surgery.

 

With best ICOSIM regards

Your Hans Lechner

24. ICOSIM Weekly

1. New PubMed publication from CaviTAU® users
„ Reduction of Inflammatory RANTES/CCL5 Serum Levels by Surgery in Patients with Bone Marrow Defects of the Jawbone“
2. Training: Global cancer increase and what we can do about it

Dear friends of ICOSIM and jawbone osteoimmunology,

 
  1. I am pleased to share a new PubMed publication by CaviTAU® users and RANTES/CCL5 Jawbone Detox®remediators Reduction of Inflammatory RANTES/CCL5 Serum Levels by Surgery in Patients with Bone Marrow Defects of the Jawbone“ 

I am glad if you like the paper.

  1. On the not so unproblematic topic of CANCER, today I am putting together three scientific facts and – fourth – the conclusion from them on osteoimmunology of the jaw and CaviTAU®. That our approach to RANTES/CCL5 remediation and the detection of the sources in the jaw is correct, as shown by the above scientific publication.
  1. Startling scientific statistic: cancer cases in under-50s worldwide up nearly 80% in three decades, study finds


More than one million people under the age of 50 die from cancer each year, and the number is expected to increase by another 21% by 2030. The number of global cases of early-stage cancer has increased from 1.82 million in 1990 to 3.26 million in 2019, while cancer deaths among adults aged 40, 30 years or younger increased by 27%.

More than one million people under age 50 now die of cancer each year, the study found.

The authors of the study, published in BMJ Oncology, note that poor diet, alcohol and tobacco use, physical inactivity and obesity are likely contributing factors.

“Since 1990, incidence and deaths from early-stage cancers have increased substantially worldwide,” the report states. “Promoting healthy lifestyles, including a healthy diet, limiting tobacco and alcohol use, and adequate outdoor exercise, could reduce the burden of early-stage cancer.”

The recent study, led by the University of Edinburgh in Scotland and Zhejiang University School of Medicine in Hangzhou, China, was the first of its kind to examine the issue on a global scale and risk factors for younger adults. Most of the previous studies focused on regional and national differences. In this global study, researchers analyzed data from 204 countries on 29 cancer types.

In 2019, a total of 3.26 million new cancer diagnoses were made among those younger than 50 years, a 79% increase from 1990. Breast cancer was the most common cancer and the most common cause of death, with 13.7 and 3.5 cases per 100,000 of the global population, respectively.

In 2019, a total of 1.06 million people under the age of 50 died from cancer, a 27% increase from 1990. After breast cancer, most deaths were associated with cancers of the trachea, lung, stomach, and intestine.

Based on trends observed over the past three decades, researchers estimate that the number of new cancer cases and associated deaths worldwide will increase by another 31% and 21%, respectively, by 2030, with people in their 40s most at risk.

Dr. Claire Knight, a senior health information manager at Cancer Research UK who was not involved in the study, said it is not yet clear what is driving this trend and urged caution. “If people are concerned about their cancer risk, there are many ways to reduce it, such as not smoking, eating a balanced diet, getting plenty of exercise and staying safe in the sun.

  1. Fact #2: Cancer and RANTES / CCL5

What does the scientific literature say about RANTES/CCL5 and tumors? Searching for “Cancer review … or Breast cancer …or Prostate cancer…or Colon cancer AND RANTES CCL5” in the science database GoogleScholar yields surprising results:
  1. Fact #3: RANTES / CCL5 and CaviTAU®

Research shows that conspicuous bone softening in the jaw (FDOJ) is a common, almost epidemic phenomenon in old extraction and implant sites. Please refer to:

  1. Lechner J, von Baehr V. RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int. Jour. of General Medicine; 2013:6 Pages 277 – 290, DOI: https://dx.doi.org/10.2147/IJGM.S43852
  2. Lechner J, von Baehr V. Hyperactivated Signaling Pathways of Chemokine RANTES/CCL5 in Osteopathies of Jawbone in Breast Cancer Patients—Case Report and Research. Breast Cancer: Basic and Clinical Research 2014:8 89–96 DOI. https://doi.org/10.4137%2FBCBCR.S15119
  3. Lechner J, Schmidt M, von Baehr V, Schick F. Undetected Jawbone Marrow Defects as Inflammatory and Degenerative Signaling Pathways: Chemokine RANTES/CCL5 as a Possible Link Between the Jawbone and Systemic Interactions?. J Inflamm Res. 2021;14:1603-1612. https://doi.org/10.2147/JIR.S307635
  4. Lechner J, Schulz T, Lejeune B, von Baehr V. Jawbone Cavitation Expressed RANTES/CCL5: Case Studies Linking Silent Inflammation in the Jawbone with Epistemology of Breast Cancer. Breast Cancer (Dove Med Press). 2021;13:225-240 https://doi.org/10.2147/BCTT.S29548

  1. The logic from #1 + #2 + #3 yields the ICOSIM proposal for the cancer question:

  1. Wouldn’t a systematic screening for “Silent Inflammation” in the jaw and thus for potentially cancer-causing RANTES/CCL5 “foci” radiation-free and non-invasive with CaviTAU® ultrasound sonography be a preventive and revolutionary addition to the smoke- and meat-free sedentary life?
  2. Wouldn’t the systematic search for the causes of cancer development with detection of “silent inflammation” in the jaw with radiation-free ultrasound be the more effective supplement to the much-discussed X-ray mammography?

With this I remain until the next ICOSIM-Weekly with collegial greetings.


Yours
Hans Lechner

23. ICOSIM Weekly

1. Immunological sustainability of titanium implants
2. Abstract for the article
3. Don´t miss the date:
Blood Concentrate Day Frankfurt 15. Sep. 2023

Dear friends of ICOSIM and jawbone osteoimmunology,

 

Has implantology already reached its scientific endpoint? In the daily routine of implanting is everything perfect or are we forgetting hidden stresses on the immune system?

 

1. A possible answer is given in this Weekly – By the abstract for the latest publication of our Munich Research Team MRT:

Immunological sustainability of titanium implants?
Osteoimmunology and osseointegration in dissolved titanium particles

 

Abstract: The bone-implant contact (BIC) is the essential prerequisite for successful osseointegration and implant stability. If this BIC does not occur on the entire surface of the implant, osseointegration is disturbed and local chronic inflammations in the sense of osteoimmunology can occur. These fatty-degenerative osteonecroses of the jawbone (FDOJ) endanger the immunological sustainability of the implantation; they harm the patient systemically by local RANTES/CCL5 overexpression at the implant-bone interfaces. Since no technique has yet been developed to visualize and verify whether bone or soft tissue is actually present around implants (Albrektsson 2023), these bone marrow defects at the BIC of implants have not been explored. A computerized transalveolar ultrasound system covers that diagnostic gap of standard X-ray techniques. A clinical case presentation demonstrates the immunological relevance of the problem and shows the solution using complementary dental sonography.

 

2. Curious? This is the PDF download of the original IMPLANTS article in English

Immunological sustainability of titanium implants? 
Osteoimmunology and osseointegration in dissolved titanium particles

3. Save the Date: International Blood Concentrate Day Frankfurt 15. Sep. 2023

 
 

Topic of the Dr. Lechner lecture:Bone Ultrasound Detection of Difficult to Diagnose Bone Affections after Extraction and/or Implantation”. 

 

 

Topic of the Dr. Lechner workshop:Between Osseointegration and Osteoimmunology – Practice of Ultrasound Sonography for Immunological Sustainability of Titanium and Ceramic Implants

 

 

I remain until the next ICOSIM Weekly with collegial greetings in preparation for the event in Bad Kissingen at the IGAF and the Blood Concentrate Day with Prof. Ghanaati in Frankfurt.

 

Yours,
Hans Lechner

 

22. ICOSIM Weekly

1. The call for VitD? Cure or fake?
2. 113 RANTES citations!
3. Don’t miss the date: Blood Day Frankfurt 15.Sept 2023

Dear friends of ICOSIM and jawbone osteoimmunology,

After the summer break with fresh forces: New and interesting in jawbone osteoimmunology!!

 

1. The call for VitD? Cure or fake?

 

Who doesn’t know it: The loud call for VitD? Under the title “Cancer Mortality” is a press release from the German Cancer Research Center (DKFZ). (Editor: Marc Fröhling) to read that according to the current study situation, vitamin D intake is associated with a reduced cancer mortality.

Are we all taking VitD now and fighting cancer!? Upon closer inspection, the DKFZ researchers found significantly lower serum levels of the pro-inflammatory tumor necrosis factor alpha (TNF alpha) and interleukin 6 and CRP in study participants under VitD substitution. Problem for us ICOSM members:

Exactly TNF alpha, IL-6 and CRP play no role according to our research in the osteoimmunology of the jawbone: All three are extremely under-expressed and therefore not a necessary target for VitD substitution as our research with IMD-Berlin shows:

On the contrary, it turns out: Since an initial activation of TNF alpha, IL-6 is essential for wound healing of an FDOK, the anti-inflammatory VitD further suppresses the osteoimmunological activation of osteoneogenesis of an FDOK.

Quintessence:

The importance of VitD remains of course. But a blanket high-dose therapy regimen for bone healing in the jaw in FDOK and implantation should be approached with due caution.

P.S. See also our publication : (Read here)

Lechner J, Aschoff J, Rudi T. The vitamin D receptor and the etiology of RANTES/CCL- expressive fatty-degenerative osteolysis of the jawbone: an interface between osteoimmunology and bone metabolism. Int J Gen Med. 2018; 11:155–66. https://doi.org/10.2147/IJGM.S152873 PMID: 29731660.

2. 113 RANTES citations!

 

Does our research with IMD-Berlin on jawbone osteoimmunology find recognition in international scientific literature?

Not without pride I note: Our publications on RANTES/CCL5 and FDOK have been cited 113 times so far (of course without self-citations).

 

3. Save the Date: International Blood Concentrate Day Frankfurt 15.Sept 2023

 

Topic Lechner Lecture:Bone Ultrasound Detection of Difficult to Diagnose Bone Affections after Extraction and/or Implantation”. 

 

 

Topic Lechner Workshop:Between Osseointegration and Osteoimmunology– Practice of Ultrasound Sonography for Immunological Sustainability of Titanium and Ceramic Implants

 

 

Remain until the next ICOSIM Weekly with collegial greetings in preparation for the event in Bad Kissingen at IGAF and Blood Day with Prof. Ghanaati in Frankfurt
Your Hans Lechner

 

Your
Hans Lechner

 

21. ICOSIM Weekly

1. ICOSIM: Live surgery at Jawbone Detox Days 14/15 July
2. RANTES and developmental defects of enamel in children
3. Save the date: 17th Sep. Lecture by Dr. Lechner about Immune regulation and chronic inflammation in the jaw

Dear ICOSIM Friends and Osteoimmunology Members,

before we say goodbye for the summer break, a short note on our own behalf:
after the 100th ICOSIM Weekly from the beginning of July, we have decided to publish the Weekly fortnightly.

Always worth reading and informative for what is new in osteoimmunology of the jaw bone!!!

1. Our JAWBONE DETOX DAYS® has been very successful

on July 14th/15th, with our colleagues from the Munich Research Team-MRI Dr. Florian Notter and Dr. Fabian Schick:

With modern digital technology, two FDOK live surgeries were transmitted from our practice clinic to the pleasant (plus 37 Celsius) hotel for the participants.

The latest findings in regulative-immunological dentistry IMMUNE DENTISTRY with revolutionary new multimodal concept for therapy planning in jaw rehabilitation and implantology were presented by Hans Lechner.


Learn more about the concept to ensure individual success in diagnosis and therapy in our upcoming JAWBONE DETOX DAYS® in the ICOSIM Weekly!

The impressive lecture by Dr. Andres Fernandez from Costa Rica contributed to the international exchange of experience and lively discussion among colleagues:

2. ARTICLE: RANTES and developmental defects of enamel in children

Who does not know it? The helpless shrug of the shoulders of worried parents: Their child already has terrible enamel defects on the milk teeth!

Here is a paper with reference to enamel defects to RANTES/CCL5: Read the paper

[Costa EM, Pinho JRO, Saraiva MdCP, Ribeiro CCC, Batista RFL, Coêlho Alves CM, et al. (2023) RANTES and developmental defects of enamel in children: a Brazilian prenatal cohort (BRISA). PLoS ONE 18(7): e0284606. https://doi.org/10.1371/journal.pone.0284606].
 

Conclusion: Lower RANTES concentrations in the blood during during pregnancy may affect the process of amelogenesis, because this chemokine affects cellular depolarization, which is induced by the sustained influx of calcium (Ca++) and the release of inflammatory inflammatory cytokines that promote cell adhesion/aggregation is triggered.

P.S. One also cites at [40] our own publication: Go to publication

Lechner J, Aschoff J, Rudi T. The vitamin D receptor and the etiology of RANTES/CCL- expressive fatty-degenerative osteolysis of the jawbone: an interface between osteoimmunology and bone metabolism. Int J Gen Med. 2018; 11:155-66. https://doi.org/10.2147/IJGM.S152873 PMID: 29731660.

3. Save the date: 17.09. Lecture by Dr. Lechner


Immune regulation and chronic inflammation in the jaw

Our connection to Integrative Oral Medicine IOM creates the International Society for Autonomic Functional Diagnostics and Regulatory Medicine IGAF.

At the IGAF Symposium in Bad Kissingen, Germany, Hans Lechner will lecture on September 17, 2023: “Immune Regulation and Chronic Inflammation in the Jaw – Data and cases on system-oriented remediation practice”.

 

Remain until the next ICOSIM Weekly with collegial greetings in the preparations for the event in Bad Kissingen at IGAF

 

Your
Hans Lechner

 

20. ICOSIM Weekly – New article with op-videos – Over 44 tsd. listeners QS 24 Health TV.

Dear ICOSIM members,

ICOSIM Weekly has not fallen asleep: I am back from vacation!

  1. In this ICOSIM Weekly the overview of four NEW broadcasts on the channel QS24 of the Swiss Health TV: We have reached more than 44.000 viewers and convinced them of the novel contents of our Integrative Oral Medicine IOM.

Please take a look for yourself and learn IOM!

Chronic diseases: Cooperation between physicians and dentists
Dr. med. dent. Dr. Johann Lechner | NaturMedizin | QS24
Health Television

Broadcast date:
Sat. 09.04.2022; 09:30 p.m.

Is stress regulation present at all?
Dr. med. dent. Dr. Johann Lechner | NaturMedizin | QS24
Health Television

Broadcast date:
Sat. 04/23/2022; 9:30 p.m.

Rantes Trigger: Firing the Cytokine Storm
Dr. med. dent. Dr. Johann Lechner | NaturMedicine | QS24
Health Television

Broadcast Date:
Sat. 05/07/2022; 9:30 p.m.

Search for the cause of dermatitis
Dr. med. dent. Dr. Johann Lechner | NaturMedizin | QS24
Health Television

Broadcast date:
Sat. 05/21/2022; 09:30 p.m.

Please note: All 19 QS 24 videos by Hans Lechner can also be viewed on our practice channel! 
  1. In the professional journal “Applied Complementary Medicine AKOM 6/2022” we have published a new article: From Holistic Dentistry to Integrative Oral Medicine – Video documentation on interference field remediation in the jaw.

I wish you a lot of fun watching QS24, reading the article and watching the video – I hope it is worthwhile to get further insight into the completely new discipline of a “Maxillo-mandibular Osteoimmunology”.

and remain with best ICOSIM greetings

Your Hans Lechner

19. ICOSIM Weekly – CaviTAU goes Washington DC – Ceramic Implant Congress

Dear ICOSIM members,

due to my vacation a today delayed ICOSIM-Weekly: Our CaviTAU developer team was in Washington DC.,USA from May 19-21, 2022 and could demonstrate the leading role of CaviTAU in the use of ceramic implants in front of more than 100 participants.

Here is the title and abstract of my talk in English:

Ultrasonography versus radiography in the assessment of jawbone density in preparation for implant placement- A novel approach

A new ultrasonography device generates an ultrasound wave and passes that wave through the jawbone, called “Trans Alveolar Ultrasonography (TAU)”. Will a newly available TAU device answer the questions:

  • Is the jawbone ready for implant insertion?
  • Or is the implant connected to persisting bone marrow defects?
  • Or connected to aseptic necrotic bone and poses a risk to implant placement?

Ultrasonography device CaviTAU® is developed for the radiation-free measurement of bone density and suitable to visualize the condition of jawbone beyond radiography. TAU device CaviTAU® displays load-free jawbones for non-problematic and durable implant insertion and is available to detect radiographically undetectable “silent inflammations” around persisting “unexplainable painful” implants.

In the daily praxis and for your daily implant success measuring bone density by TAU ultrasonography before and after implantation avoids failures. TAU protects dentists and patients from the early loss of implants. Impressive clinical cases are presented by the presenter.

TAU device CaviTAU® displays a new insight into an under recognized entity of “silent inflammation” in jawbone and is a reliable guide to “jawbone detox”. For further information please visit www.cavitau.de.

I wish you a lot of fun reading – I hope it is worthwhile to get further insight into the completely new field of a “Maxillo-mandibular Osteoimmunology” –

and remain with best ICOSIM greetings

Yours, Hans Lechner

18. ICOSIM Weekly – Lechner lecture DEGUZ – New publication in CeramicImplants 2/2022

Dear ICOSIM colleagues,

First reminder: sent back the vote for ICOSIM already?

  1. In this ICOSIM Weekly for all who could not be present at the DEGUZ in Frankenthal.

    Here to download my presentation:
    Insight into the jawbone: Inflammatio due to implant? Inflammatio by Endo?

  1. In Ceramic Implant 2/2022 again an international publication by Hans Lechner in English with the title:
    Dental Implants and Bone Marrow Defects – Evaluation of Bone Quality by Intraoral Ultrasonography

I hope you enjoy reading this article – I hope it will be worth your while to gain further insight into the completely new field of “Maxillo-mandibular Osteoimmunology” – and I leave you with my best wishes.

and remain with best ICOSIM greetings

Yours, Hans Lechner

17. ICOSIM Weekly – General meeting circulation procedures; OR videos; next FDOJ documentary; health TV QS24.

Dear ICOSIM colleagues,

  1. General meeting by circulation! 

    You will receive mail from ICOSIM e.V. in the next days.
    Essentially, the items on the agenda are about making the association more flexible and powerful by expanding different types of memberships.
    Additionally we have the possibility to expand and finance science and education in ICOSIM.

    I ask you to return the enclosed ballot to the business address of ICOSIM e.V. by 05/20/22.

  1. I hope that our new life surgery videos have been liked and found interest in the undeniable documentation of the existence of FDOJ pathology. As a reminder download for ICOSIM members at

In addition, here is the LINK to download FDOJ documentation for tumor patients PDF; I wish you good entertainment and profound information about CaviTAU®.

  1. The figure shows from the weekly report of the scientific database Researchgate how far our publications get international attention: in the last week of February the curve shows more than 100 links and in 1 week up to 30 readers, from “all over the world”!

Your Hans Lechner